GSK PLC 17 April 2024 Issued: 17 April 2024, London UK EAGLE-1 phase III data show potential for gepotidacin as a new oral treatment option...
GSK PLC 17 April 2024 Issued: 17 April 2024, London UK New long-term data show Shingrix continues to provide high protection against...
GSK PLC 16 April 2024 The following amendment has been made to the 'Director/PDMR Shareholding' announcement released on 15 April 2024 at...
GSK PLC on Tuesday said it has made progress in the development of its newest candidate, which combines the strengths ...
GSK PLC 16 April 2024 Issued: 16 April 2024, London UK GSK's 5-in-1 meningococcal ABCWY vaccine candidate accepted for regulatory review by...
GSK PLC 15 April 2024 GSK plc (the 'Company') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name...
Barclays on Monday increased its share price target for GSK after adding in forecasts for five key pipeline assets. ...
GSK PLC 04 April 2024 The following amendment has been made to the 'Total Voting Rights and Capital' announcement released on 2 April 2024 at...
GSK PLC 02 April 2024 GSK plc Total Voting Rights and Capital In conformity with the Financial Conduct Authority's Disclosure Guidance and...
GSK PLC 26 March 2024 GSK plc (the 'Company') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a...
GSK PLC 25 March 2024 GSK plc (the 'Company') Publication of Notice of Annual General Meeting 2024 The Company has today published on its...
GSK PLC 22 March 2024 GSK plc (the 'Company') Transfer of Treasury Shares On 21 March 2024, the Company transferred 27,800,000 ordinary...
GSK PLC 22 March 2024 GSK plc (the 'Company') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.